Top Markets
Coin of the day
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Rang in aandelen #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Aandeelprijs
$0.0009
Laatst gesynchroniseerd: 2025-05-27
Marktkapitalisatie
$1.15K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Arch Therapeutics, Inc. (ARTH)

Categorie

Prijs ARTH met de marktkapitalisatie van B
Arch Therapeutics, Inc. Arch Therapeutics, Inc.
ARTH
$0.0009
Marktkapitalisatie van Arch Therapeutics, Inc.(ARTH)
Marktkapitalisatie: $1.15K
Vanaf August 2026 heeft Arch Therapeutics, Inc. een marktkapitalisatie van $1.15K. Dit maakt Arch Therapeutics, Inc. volgens onze gegevens het 42478th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Arch Therapeutics, Inc. van 2012 tot 2026
ARTH vergeleken met de top 5 populairste stocks
Prijs voor ARTH Aandeel B Marktkapitalisatie van B uitslagen
Arch Therapeutics, Inc. Arch Therapeutics, Inc.
$4,205,858 $1.15K
$5.383T +467,317,564,399.94%
Arch Therapeutics, Inc. Arch Therapeutics, Inc.
$3,463,781 $1.15K
$4.434T +384,864,553,791.02%
Arch Therapeutics, Inc. Arch Therapeutics, Inc.
$3,247,965 $1.15K
$4.157T +360,885,012,537.75%
Arch Therapeutics, Inc. Arch Therapeutics, Inc.
$2,862,043 $1.15K
$3.663T +318,004,804,195.33%
Arch Therapeutics, Inc. Arch Therapeutics, Inc.
$2,258,831 $1.15K
$2.891T +250,981,196,514.80%